101 related articles for article (PubMed ID: 10088172)
21. Comparative evaluation of Tc-99m cystine and Tc-99m MAG3 in normals and patients with renal functional impairment.
Misra M; Pradhan PK; De K; Chandra S; Das BK
Clin Nucl Med; 2009 Mar; 34(3):141-5. PubMed ID: 19352274
[TBL] [Abstract][Full Text] [Related]
22. A single-injection, two-sample method for measuring renal 99mTc-MAG3 clearance in both children and adults.
Russell CD; Taylor AT; Dubovsky EV; Eshima D
Nucl Med Biol; 1995 Jan; 22(1):55-60. PubMed ID: 7735170
[TBL] [Abstract][Full Text] [Related]
23. Re: Taylor et al.: a 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function (Urology 2010;76:1512-1516).
Zuckier LS
Urology; 2011 Apr; 77(4):1011; author reply 1011-2. PubMed ID: 21477735
[No Abstract] [Full Text] [Related]
24. Kidney function after nephrectomy for renal cell carcinoma.
Shirasaki Y; Tsushima T; Saika T; Nasu Y; Kumon H
Urology; 2004 Jul; 64(1):43-7; discussion 48. PubMed ID: 15245931
[TBL] [Abstract][Full Text] [Related]
25. 99mTc-MAG3 renography: normal values for MAG3 clearance and curve parameters, excretory parameters, and residual urine volume.
Esteves FP; Taylor A; Manatunga A; Folks RD; Krishnan M; Garcia EV
AJR Am J Roentgenol; 2006 Dec; 187(6):W610-7. PubMed ID: 17114514
[TBL] [Abstract][Full Text] [Related]
26. Administered activity optimization in 99mTc-MAG3 renography for adults.
Díaz MP; Aparicio EE; Rizo OD; Díaz RR; Rodríguez CH
J Nucl Med Technol; 2003 Dec; 31(4):216-21. PubMed ID: 14657288
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of single-sample clearance of 99mTc-mercaptoacetyltriglycine and 131I-orthoiodohippurate.
Russell CD; Dubovsky EV
J Nucl Med; 1999 Jul; 40(7):1122-4. PubMed ID: 10405130
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice.
Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ
Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269
[TBL] [Abstract][Full Text] [Related]
29. Dosimetry of
Arteaga MV; Caballero VM; Rengifo KM
Appl Radiat Isot; 2018 Aug; 138():25-28. PubMed ID: 28781122
[TBL] [Abstract][Full Text] [Related]
30. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
[TBL] [Abstract][Full Text] [Related]
31. Transport of 99mTc-MAG3 via rat renal organic anion transporter 1.
Shikano N; Kanai Y; Kawai K; Ishikawa N; Endou H
J Nucl Med; 2004 Jan; 45(1):80-5. PubMed ID: 14734677
[TBL] [Abstract][Full Text] [Related]
32. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
33. Uterine myoma identified on a Tc-99m MAG3 scan of a renal transplant.
Liu Y; Park T; Chun KJ; Freeman LM
Clin Nucl Med; 2002 Nov; 27(11):801-2. PubMed ID: 12394131
[No Abstract] [Full Text] [Related]
34. Study on 99mTc-MAG3 and 99mTc-DMSA renal accumulation using in vitro cellular model.
Nový Z; Mandíková J; Trejtnar F
Ceska Slov Farm; 2011 Feb; 60(1):7-10. PubMed ID: 21648170
[TBL] [Abstract][Full Text] [Related]
35. Tc-99m mercaptoacetyltriglycine clearance: comparison of camera-assisted methods.
Bocher M; Shrem Y; Tappiser A; Klein M; Schechter D; Taylor A; Chisin R
Clin Nucl Med; 2001 Sep; 26(9):745-50. PubMed ID: 11507290
[TBL] [Abstract][Full Text] [Related]
36. 99Tcm-MAG3: a sensitive indicator for evaluating perfusion and rejection of renal transplants.
Oriuchi N; Miyamoto K; Hoshino K; Imai J; Takahashi Y; Sakai S; Shimada A; Endo K
Nucl Med Commun; 1997 May; 18(5):400-4. PubMed ID: 9194080
[TBL] [Abstract][Full Text] [Related]
37. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
Li Y; Tan T; Zheng J; Zhang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
[TBL] [Abstract][Full Text] [Related]
38. [Determinations of MAG3 clearance according to the whole-body principle and to related methods].
Sonntag A
Nuklearmedizin; 1996 Aug; 35(4):132-9. PubMed ID: 9005407
[TBL] [Abstract][Full Text] [Related]
39. Transport of 99mTc-MAG3 via rat renal organic anion.
Blaufox MD
J Nucl Med; 2004 Jan; 45(1):86-8. PubMed ID: 14734678
[No Abstract] [Full Text] [Related]
40. [Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs].
Fan C; Hnatowich DJ
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):712-5. PubMed ID: 18693462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
